SCHEMBL1131853

SCHEMBL1131853

CC(=Cc1nn(C2CCCCC2)c(-c2ccc(OCc3ccccc3)cc2)c1Br)C(=O)O

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
BTK Q06187 3/20 0.42
PTPN1 P18031 3/20 0.42
CHRNB2 P17787 1/20 0.41
CHRNA5 P30532 1/20 0.41
CHRNA7 P36544 1/20 0.41
CHRNA4 P43681 1/20 0.41
CMKLR1 Q99788 4/20 0.41
HRH3 Q9Y5N1 1/20 0.40
KDM4E B2RXH2 4/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
KMT2A Q03164 1/20 0.40
ALDH1A1 P00352 2/20 0.39
HPGD P15428 1/20 0.39
RXFP1 Q9HBX9 1/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1132025 0.90 PTPN1 (0.43) BTKPTPN1CHRNB2CHRNA5CHRNA7
SCHEMBL1132086 0.87 HRH3 (0.41) BTKCMKLR1HRH3
SCHEMBL1131332 0.86 PTGS1 (0.41) BTKCMKLR1HRH3KDM4ESMN1; SMN2
SCHEMBL1132052 0.86 PTGS1 (0.41) BTKCMKLR1HRH3KDM4ESMN1; SMN2
SCHEMBL1131587 0.85 CMKLR1 (0.39) BTKCMKLR1KDM4ESMN1; SMN2KMT2A
SCHEMBL1131591 0.85 CMKLR1 (0.39) BTKCMKLR1KDM4ESMN1; SMN2KMT2A
SCHEMBL1131589 0.83 CNR1 (0.40) BTKCMKLR1HRH3KDM4ESMN1; SMN2
SCHEMBL1131696 0.83 KDM4E (0.43) BTKCMKLR1HRH3KDM4ESMN1; SMN2
SCHEMBL1131586 0.81 FABP3 (0.45) BTKPTPN1CHRNB2CHRNA5CHRNA7
SCHEMBL1131282 0.81 FABP3 (0.45) BTKPTPN1CHRNB2CHRNA5CHRNA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1663105-B1 CYCLOALKYL HETEROCYCLES FOR TREATING HEPATITIS C VIRUS BRISTOL MYERS SQUIBB CO (US) 2011-02-16 EP disclosed